latest blog entries
Loading...
Branding...
latest headlines for company on cafepharma
Pharmaceutical Business Review
Wed, 06/29/11 - 7:30 am
Investopedia
Sat, 09/11/10 - 11:35 am
Reuters
Wed, 06/30/10 - 10:00 am
tags: cladribine, Gilenia, Merck KGaA, Merck Serono, MS, multiple sclerosis
Yahoo/PR NewsWire
Thu, 06/17/10 - 9:19 am
Yahoo/AP
Mon, 05/24/10 - 7:54 am
tags: antidepressants, Clinical Data, FDA, Merck Serono, Vilazodone
TheStreet.com
Wed, 04/07/10 - 10:01 am
Marketwatch
Thu, 03/25/10 - 9:38 am
tags: Biogen Idec, Copaxone, Elan, Merck Serono, Rebif, Teva Pharmaceuticals, Tysabri
Seeking Alpha
Mon, 11/30/09 - 11:25 am
tags: China, Gilead Sciences, GSK, IPOs, Merck Serono, Pfizer, Sinovac
Bizjournals.com
Fri, 09/11/09 - 8:50 am
BNET Pharma
Fri, 01/09/09 - 1:30 pm
Last 30 twitter posts
-
Merck Serono et Quintiles annoncent un partenariat de développement clinique innovant t.co/zvV4XiHIKb
-
Merck Serono et Quintiles annoncent un partenariat de développement clinique innovant t.co/XjyZXlVaaQ
-
@zozy74 1- esmha merck serono 2- iam a pharmacist 3- i work for pfizer 3la fekra b2a :p
-
Merck Serono and Quintiles Announce Innovative Clinical Development Partnership t.co/uixWmvmBFh
-
Merck Serono and Quintiles Announce Innovative Clinical Development Partnership t.co/k1lJDlJ1Sa
-
New drug model? Quintiles to develop compounds with Merck Serono t.co/vOjcQCfJ7F
-
#Entrepreneurship Merck Serono increases funding commitment for MS Ventures - Zenopa t.co/IcHDyxlvnf
-
@Mercksalud, t.co/qpucXhs4jY vía @la_informacion
-
RT @Currentpartner: #Merck Serono Ventures nets $77.4 in #financing facility from Merck KGaA| t.co/HKTZ5BnVUP #pharma #venturecapital
-
#Merck Serono Ventures nets $77.4 in #financing facility from Merck KGaA| t.co/HKTZ5BnVUP #pharma #venturecapital
-
RT @PharmaNewsDaily: Pharma News: Merck Serono, Quintiles sign five-year clinical development agreement t.co/V04bV5JxFs
-
Merck Serono Increases its Commitment to MS Ventures to €100 Million-t.co/orxgHDukWo #merck_serono #medical #venture #biotech
-
¡Save the Date! 27 de junio 2013 Acto de Entrega de Ayudas Merck Serono de #Investigación en el CSIC (Madrid) ¿Nos acompañan? #AyudasMS2013
-
Pharmaceutical News: Merck Serono increases funding commitment for MS Ventures t.co/681aI8zuul
-
Merck Serono and Quintiles team up for drug development... t.co/tt1FDoFxSM
-
Merck Serono et Quintiles annoncent un partenariat de développement clinique t.co/CBp25pWLNc
-
Merck Serono, Quintiles sign five-year clinical development agreement t.co/wYOex5r0S9
-
Merck Serono and Quintiles in partnership t.co/eWBP1RiRIk
-
PharmiWeb Today: Merck Serono and Quintiles Announce Innovative Clinical Development Partnership: M... t.co/ed0peWYj6u #pharmiweb
-
#pharminews Merck Serono and Quintiles Announce Innovative Clinical Development Partnership t.co/vsMHkuZtdB
-
Good story from Outsourcing Pharma on the Quintiles / Merck Serono agreement. t.co/yQVziDjk5n
-
RT @ScripMikeWard: #Merck #Serono increases commitment to MS Ventures, its corporate #vc business founded in 2009, from €40M to €100M to back #biotech #pharma
-
Merck Serono, Quintiles sign five-year clinical development agreement t.co/UEb2b1xHRv
-
#Merck Serono and #Quintiles Announce Unique Five-Year Agreement #MANDaily #CRO t.co/mZJkSRpQZL
-
#Merck Serono and #Quintiles Announce Unique Five-Year Agreement #MANDaily #CRO t.co/rKmZNb0uoH t.co/ziVh2dJ384
-
#Merck Serono and #Quintiles Announce Unique Five-Year Agreement #MANDaily #CRO t.co/rKmZNb0uoH
-
#Merck Serono and #Quintiles Announce Unique Five-Year Agreement #MANDaily #CRO t.co/4nmNep37Ci t.co/gNCgLg4kHG
-
Merck Serono and Quintiles Announce Innovative Clinical Development Partnership t.co/GjXvLjBNj7 via @financialpost
-
RT @lisamjarvis: Pharma plans to seed early innovation galore this week: Roche/QB3, Novartis/Amgen/Atlas, Merck Serono ups venture investment, etc
-
Innovative Clinical Development Partnership Announced By Quintiles and Merck Serono t.co/1ZNq5qIlWP
Latest Health Message Board Posts
... MS in the future." The study, which lasts for five years, is continuing. The research is supported by the pharmaceutical company Merck Serono S.A., of Geneva. Because this study was presented at a medical meeting, the data and conclusions should be viewed ...
Posted by:
Bettyg
at
2013-01-08 11:25:00
on
mdjunction.com
... Nederland, Neuroscience Campus Amsterdam, and the Prinses Beatrix Fonds. Several co-authors reported relationships with Eisai, Merck-Serono, Novartis, Cephalon, UCB, Boehringer Ingelheim, and Valeant. One also reported holding patents related to some ...
Posted by:
Nikodicreta
at
2013-01-04 06:00:00
on
medhelp.org
... ibuprofen. The study was funded by the National Institutes of Health. One co-author of the study reported honoraria from Merck Serono. Other study authors and the editorialists reported no financial interests other than research funding from government and ...
Posted by:
sandythegeek2
at
2012-04-19 05:00:00
on
medhelp.org
... relationships with Novartis, Pfizer, Aylin Pharmaceuticals, American Medical Systems, Nordic Biotech, Helsinn Healthcare, Merck Serono, and Sucampo Pharmaceuticals. Primary source: Neurology Source reference: Savica R, et al "Medical records documentation ...
Posted by:
Bettyg
at
2012-04-13 03:24:00
on
mdjunction.com
... for review activities, Genentech, Merck Serono, Roche; board membership, Board of Directors of Active Biotech, Sweden; consultancy, Elan, Merck Serono; speaking fees, Bayer Health Care, Merck Serono, Serono Symposia International Foundation, Sanofi-Aventis ...
Posted by:
Bettyg
at
2011-11-07 12:43:00
on
mdjunction.com
... were employees of the company) and several other corporate entities including Novartis, Schwarz Pharma/UCB, Merck-Serono, Eisai, Solvay, General Electric, Lundbeck, GlaxoSmithKline, Novartis, Teva, AstraZeneca, General Electric, Sanofi, Euth�rapie ...
Posted by:
Bettyg
at
2011-03-03 15:56:00
on
mdjunction.com
... well. The study was funded by Boehringer Ingelheim. Study authors reported relationships with Boehringer Ingelheim, BrainCells, Merck Serono, Novartis, Ovation, Wyeth, Mohegan Sun Casino, Forest Laboratories, National Center for Responsible Gaming (and its ...
Posted by:
Bettyg
at
2011-02-02 22:01:00
on
mdjunction.com
... Pharma, and BTG International. He has received speaker honoraria from Bayer Schering Pharma, sanofi-aventis, Bracco, Merck Serono, Teva Pharmaceutical Industries, and Biogen Idec. He receives research support from Bayer Schering Pharma. Montalban has ...
Posted by:
Bettyg
at
2010-08-19 02:31:00
on
mdjunction.com
... , and the Michael J. Fox Foundation. Weintraub reported relationships with Pfizer, CHDI, Teva Pharmaceutical, Avanir Pharmaceuticals, Merck Serono, Novartis, Movement Disorders, the NIH/NINDS, and the Michael J. Fox Foundation for Parkinson's Research and ...
Posted by:
Bettyg
at
2010-05-12 02:13:00
on
mdjunction.com
... , Biogen, Pfizer, Avanir Pharmaceuticals, and Merck. Co-authors disclosed relationships with the Michael J. Fox Foundation, National Parkinson Fundation, Teva, Ipsen, Schering-Ploough, Merck Serono, and General Electric. Co-authors included an employee ...
Posted by:
Bettyg
at
2010-05-11 02:04:00
on
mdjunction.com